How big is the sickle cell anemia therapeutics market?

The disease is caused by a genetic mutation in the betachain of hemoglobin which results in the formation of abnormal hemoglobin known as sickle hemoglobin HbS.HighlightsThe global Sickle Cell Anemia Therapeutics market was valued at US 3913.6 million in 2022 and is anticipated to reach US 9388.1 million by 2029 witnessing a CAGR of 15.7 during the forecast period 20232029.

BUY CHAPTERS

Global Sickle Cell Anemia Therapeutics Market Research Report 2023

Code: QYRE-Auto-26Q12719

Report

January 2023

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Global Blood Therapeutics

Micelle BioPharma

Bluebird bio

Prolong Pharmaceuticals

Ironwood Pharmaceuticals

Sickle Cell Anemia Therapeutics Market Size

The global Sickle Cell Anemia Therapeutics market was valued at US$ 3913.6 million in 2022 and is anticipated to reach US$ 9388.1 million by 2029, witnessing a CAGR of 15.7% during the forecast period 2023-2029.

Sickle Cell Anemia Therapeutics Market

Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Sickle Cell Anemia Therapeutics key players include Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, etc.

Americas is the largest market, with a share about 55%, followed by Europe, and Middle East & Africa, both have a share over 35 percent.

In terms of product, Blood Transfusion is the largest segment, with a share over 35%. And in terms of application, the largest application is Child, followed by Adult.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sickle Cell Anemia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Anemia Therapeutics.

The Sickle Cell Anemia Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Sickle Cell Anemia Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sickle Cell Anemia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Sickle Cell Anemia Therapeutics Market Report

Report Metric	Details
Report Name	Sickle Cell Anemia Therapeutics Market
Accounted market size in 2022	US$ 3913.6 million
Forecasted market size in 2029	US$ 9388.1 million
CAGR	15.7%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Blood Transfusion Pharmacotherapy Bone Marrow Transplant
Segment by Application	Child Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma, Bluebird Bio, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell Anemia Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Sickle Cell Anemia Therapeutics Market market growing?

Ans: The Sickle Cell Anemia Therapeutics Market market witnessing a CAGR of 15.7% during the forecast period 2023-2029.

What is the Sickle Cell Anemia Therapeutics Market market size in 2029?

Ans: The global Sickle Cell Anemia Therapeutics market was valued at US$ 3913.6 million in 2022 and is anticipated to reach US$ 9388.1 million by 2029, witnessing a CAGR of 15.7% during the forecast period 2023-2029.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Blood Transfusion

1.2.3 Pharmacotherapy

1.2.4 Bone Marrow Transplant

1.3 Market by Application

1.3.1 Global Sickle Cell Anemia Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Child

1.3.3 Adult

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sickle Cell Anemia Therapeutics Market Perspective (2018-2029)

2.2 Sickle Cell Anemia Therapeutics Growth Trends by Region

2.2.1 Global Sickle Cell Anemia Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Sickle Cell Anemia Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Sickle Cell Anemia Therapeutics Market Dynamics

2.3.1 Sickle Cell Anemia Therapeutics Industry Trends

2.3.2 Sickle Cell Anemia Therapeutics Market Drivers

2.3.3 Sickle Cell Anemia Therapeutics Market Challenges

2.3.4 Sickle Cell Anemia Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue

3.1.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Sickle Cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Sickle Cell Anemia Therapeutics Revenue

3.4 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio

3.4.1 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Anemia Therapeutics Revenue in 2022

3.5 Sickle Cell Anemia Therapeutics Key Players Head office and Area Served

3.6 Key Players Sickle Cell Anemia Therapeutics Product Solution and Service

3.7 Date of Enter into Sickle Cell Anemia Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Sickle Cell Anemia Therapeutics Breakdown Data by Type

4.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2024-2029)

5 Sickle Cell Anemia Therapeutics Breakdown Data by Application

5.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Sickle Cell Anemia Therapeutics Market Size (2018-2029)

6.2 North America Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023)

6.4 North America Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sickle Cell Anemia Therapeutics Market Size (2018-2029)

7.2 Europe Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023)

7.4 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Sickle Cell Anemia Therapeutics Market Size (2018-2029)

9.2 Latin America Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Emmaus Medical

11.1.1 Emmaus Medical Company Detail

11.1.2 Emmaus Medical Business Overview

11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Introduction

11.1.4 Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.1.5 Emmaus Medical Recent Development

11.2 Addmedica

11.2.1 Addmedica Company Detail

11.2.2 Addmedica Business Overview

11.2.3 Addmedica Sickle Cell Anemia Therapeutics Introduction

11.2.4 Addmedica Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.2.5 Addmedica Recent Development

11.3 Gamida Cell

11.3.1 Gamida Cell Company Detail

11.3.2 Gamida Cell Business Overview

11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Introduction

11.3.4 Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.3.5 Gamida Cell Recent Development

11.4 GlycoMimetics

11.4.1 GlycoMimetics Company Detail

11.4.2 GlycoMimetics Business Overview

11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Introduction

11.4.4 GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.4.5 GlycoMimetics Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Detail

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Sickle Cell Anemia Therapeutics Introduction

11.5.4 Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.5.5 Pfizer Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Sickle Cell Anemia Therapeutics Introduction

11.6.4 Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.6.5 Novartis Recent Development

11.7 Global Blood Therapeutics

11.7.1 Global Blood Therapeutics Company Detail

11.7.2 Global Blood Therapeutics Business Overview

11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Introduction

11.7.4 Global Blood Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.7.5 Global Blood Therapeutics Recent Development

11.8 Micelle BioPharma

11.8.1 Micelle BioPharma Company Detail

11.8.2 Micelle BioPharma Business Overview

11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Introduction

11.8.4 Micelle BioPharma Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.8.5 Micelle BioPharma Recent Development

11.9 Bluebird Bio

11.9.1 Bluebird Bio Company Detail

11.9.2 Bluebird Bio Business Overview

11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Introduction

11.9.4 Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.9.5 Bluebird Bio Recent Development

11.10 Prolong Pharmaceuticals

11.10.1 Prolong Pharmaceuticals Company Detail

11.10.2 Prolong Pharmaceuticals Business Overview

11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction

11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.10.5 Prolong Pharmaceuticals Recent Development

11.11 Modus Therapeutics

11.11.1 Modus Therapeutics Company Detail

11.11.2 Modus Therapeutics Business Overview

11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Introduction

11.11.4 Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.11.5 Modus Therapeutics Recent Development

11.12 Sangamo Biosciences

11.12.1 Sangamo Biosciences Company Detail

11.12.2 Sangamo Biosciences Business Overview

11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Introduction

11.12.4 Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.12.5 Sangamo Biosciences Recent Development

11.13 Bioverativ

11.13.1 Bioverativ Company Detail

11.13.2 Bioverativ Business Overview

11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Introduction

11.13.4 Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.13.5 Bioverativ Recent Development

11.14 Imara

11.14.1 Imara Company Detail

11.14.2 Imara Business Overview

11.14.3 Imara Sickle Cell Anemia Therapeutics Introduction

11.14.4 Imara Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.14.5 Imara Recent Development

11.15 Ironwood Pharmaceuticals

11.15.1 Ironwood Pharmaceuticals Company Detail

11.15.2 Ironwood Pharmaceuticals Business Overview

11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction

11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)

11.15.5 Ironwood Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Global Blood Therapeutics

Micelle BioPharma

Bluebird bio

Prolong Pharmaceuticals

Ironwood Pharmaceuticals

List of Tables

Table 1. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Blood Transfusion

Table 3. Key Players of Pharmacotherapy

Table 4. Key Players of Bone Marrow Transplant

Table 5. Global Sickle Cell Anemia Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global Sickle Cell Anemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 8. Global Sickle Cell Anemia Therapeutics Market Share by Region (2018-2023)

Table 9. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 10. Global Sickle Cell Anemia Therapeutics Market Share by Region (2024-2029)

Table 11. Sickle Cell Anemia Therapeutics Market Trends

Table 12. Sickle Cell Anemia Therapeutics Market Drivers

Table 13. Sickle Cell Anemia Therapeutics Market Challenges

Table 14. Sickle Cell Anemia Therapeutics Market Restraints

Table 15. Global Sickle Cell Anemia Therapeutics Revenue by Players (2018-2023) & (US$ Million)

Table 16. Global Sickle Cell Anemia Therapeutics Market Share by Players (2018-2023)

Table 17. Global Top Sickle Cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Therapeutics as of 2022)

Table 18. Ranking of Global Top Sickle Cell Anemia Therapeutics Companies by Revenue (US$ Million) in 2022

Table 19. Global 5 Largest Players Market Share by Sickle Cell Anemia Therapeutics Revenue (CR5 and HHI) & (2018-2023)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Sickle Cell Anemia Therapeutics Product Solution and Service

Table 22. Date of Enter into Sickle Cell Anemia Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 25. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2018-2023)

Table 26. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 27. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2024-2029)

Table 28. Global Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 29. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Application (2018-2023)

Table 30. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 31. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Application (2024-2029)

Table 32. North America Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. North America Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 34. North America Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 35. Europe Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 37. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 38. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 39. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 40. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 41. Latin America Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 42. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 43. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 44. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 45. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 46. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 47. Emmaus Medical Company Detail

Table 48. Emmaus Medical Business Overview

Table 49. Emmaus Medical Sickle Cell Anemia Therapeutics Product

Table 50. Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 51. Emmaus Medical Recent Development

Table 52. Addmedica Company Detail

Table 53. Addmedica Business Overview

Table 54. Addmedica Sickle Cell Anemia Therapeutics Product

Table 55. Addmedica Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 56. Addmedica Recent Development

Table 57. Gamida Cell Company Detail

Table 58. Gamida Cell Business Overview

Table 59. Gamida Cell Sickle Cell Anemia Therapeutics Product

Table 60. Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 61. Gamida Cell Recent Development

Table 62. GlycoMimetics Company Detail

Table 63. GlycoMimetics Business Overview

Table 64. GlycoMimetics Sickle Cell Anemia Therapeutics Product

Table 65. GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 66. GlycoMimetics Recent Development

Table 67. Pfizer Company Detail

Table 68. Pfizer Business Overview

Table 69. Pfizer Sickle Cell Anemia Therapeutics Product

Table 70. Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 71. Pfizer Recent Development

Table 72. Novartis Company Detail

Table 73. Novartis Business Overview

Table 74. Novartis Sickle Cell Anemia Therapeutics Product

Table 75. Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 76. Novartis Recent Development

Table 77. Global Blood Therapeutics Company Detail

Table 78. Global Blood Therapeutics Business Overview

Table 79. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product

Table 80. Global Blood Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 81. Global Blood Therapeutics Recent Development

Table 82. Micelle BioPharma Company Detail

Table 83. Micelle BioPharma Business Overview

Table 84. Micelle BioPharma Sickle Cell Anemia Therapeutics Product

Table 85. Micelle BioPharma Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 86. Micelle BioPharma Recent Development

Table 87. Bluebird Bio Company Detail

Table 88. Bluebird Bio Business Overview

Table 89. Bluebird Bio Sickle Cell Anemia Therapeutics Product

Table 90. Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 91. Bluebird Bio Recent Development

Table 92. Prolong Pharmaceuticals Company Detail

Table 93. Prolong Pharmaceuticals Business Overview

Table 94. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product

Table 95. Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 96. Prolong Pharmaceuticals Recent Development

Table 97. Modus Therapeutics Company Detail

Table 98. Modus Therapeutics Business Overview

Table 99. Modus Therapeutics Sickle Cell Anemia Therapeutics Product

Table 100. Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 101. Modus Therapeutics Recent Development

Table 102. Sangamo Biosciences Company Detail

Table 103. Sangamo Biosciences Business Overview

Table 104. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product

Table 105. Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 106. Sangamo Biosciences Recent Development

Table 107. Bioverativ Company Detail

Table 108. Bioverativ Business Overview

Table 109. Bioverativ Sickle Cell Anemia Therapeutics Product

Table 110. Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 111. Bioverativ Recent Development

Table 112. Imara Company Detail

Table 113. Imara Business Overview

Table 114. Imara Sickle Cell Anemia Therapeutics Product

Table 115. Imara Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 116. Imara Recent Development

Table 117. Ironwood Pharmaceuticals Company Detail

Table 118. Ironwood Pharmaceuticals Business Overview

Table 119. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product

Table 120. Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)

Table 121. Ironwood Pharmaceuticals Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Sickle Cell Anemia Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Sickle Cell Anemia Therapeutics Market Share by Type: 2022 VS 2029

Figure 3. Blood Transfusion Features

Figure 4. Pharmacotherapy Features

Figure 5. Bone Marrow Transplant Features

Figure 6. Global Sickle Cell Anemia Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 7. Global Sickle Cell Anemia Therapeutics Market Share by Application: 2022 VS 2029

Figure 8. Child Case Studies

Figure 9. Adult Case Studies

Figure 10. Sickle Cell Anemia Therapeutics Report Years Considered

Figure 11. Global Sickle Cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Sickle Cell Anemia Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Sickle Cell Anemia Therapeutics Market Share by Region: 2022 VS 2029

Figure 14. Global Sickle Cell Anemia Therapeutics Market Share by Players in 2022

Figure 15. Global Top Sickle Cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Therapeutics as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Sickle Cell Anemia Therapeutics Revenue in 2022

Figure 17. North America Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Sickle Cell Anemia Therapeutics Market Share by Country (2018-2029)

Figure 19. United States Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. Canada Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. Europe Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Europe Sickle Cell Anemia Therapeutics Market Share by Country (2018-2029)

Figure 23. Germany Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. France Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. U.K. Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. Italy Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. Russia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Nordic Countries Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Region (2018-2029)

Figure 31. China Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Japan Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. South Korea Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Southeast Asia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. India Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Australia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Latin America Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Latin America Sickle Cell Anemia Therapeutics Market Share by Country (2018-2029)

Figure 39. Mexico Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Brazil Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Country (2018-2029)

Figure 43. Turkey Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Saudi Arabia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Emmaus Medical Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 46. Addmedica Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 47. Gamida Cell Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 48. GlycoMimetics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 49. Pfizer Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 50. Novartis Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 51. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 52. Micelle BioPharma Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 53. Bluebird Bio Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 54. Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 55. Modus Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 56. Sangamo Biosciences Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 57. Bioverativ Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 58. Imara Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 59. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Sickle Cell Anemia Therapeutics Market Research Report 2023

Published Date: January 2023

Report Code: QYRE-Auto-26Q12719

Global Sickle Cell Anemia Therapeutics Market Research Report 2023

FEATURED COMPANIES

Sickle Cell Anemia Therapeutics Market Size

Sickle Cell Anemia Therapeutics Market

Report Scope

Scope of Sickle Cell Anemia Therapeutics Market Report

Core Chapters

FAQ for this report

How fast is Sickle Cell Anemia Therapeutics Market market growing?

What is the Sickle Cell Anemia Therapeutics Market market size in 2029?

FEATURED COMPANIES

RELATED REPORTS